Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination
No. | 27 |
---|---|
Citation | J Thromb Haemost 15,p538-548(2017) |
Institute | Fujita Health University school of Health Science |
1st Author | T Matsui |
AR | |
PL | ○ |
HD | |
Paper types | Basic science |
Main purpose | Evaluation of mutant protein efficacy |
Disease | |
Antiplatelet drug | |
Anticoagulant drug | |
Other drug | |
Clinical specimens | |
Animal | |
Keyword | vWF, Botrocetin |